Amy Quinlan

Vice President of Finance, Vor Biopharma Inc.

Companies

Voyager Therapeutics (United States)Principal Accounting Officer May 18, 2026 to now¹
Vor Biopharma Inc.Vice President of Finance Jun 26, 2024 to Nov 8, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vor Biopharma Inc. VOR50,312 shares³$971.0K at $19.30Nov 6, 2024
Voyager Therapeutics (United States) VYGR36,749 shares⁴$75.3K at $2.05May 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 6, 2024Shares withheld for tax 206 shares at $0.86 of Vor Biopharma Inc.³
Nov 1, 2024Shares withheld for tax 343 shares at $0.80 of Vor Biopharma Inc.⁵
Sep 3, 2024Shares withheld for tax 4,402 shares at $0.83 of Vor Biopharma Inc.⁶
Aug 6, 2024Shares withheld for tax 206 shares at $0.87 of Vor Biopharma Inc.⁶
Aug 1, 2024Shares withheld for tax 343 shares at $0.94 of Vor Biopharma Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVoyager Therapeutics (United States), Principal Accounting Officer
2
SEC EDGARVor Biopharma Inc., Vice President of Finance
3
SEC EDGARVor Biopharma Inc. shares after the filing of Nov 6, 2024
4
SEC EDGARVoyager Therapeutics (United States) shares after the filing of May 18, 2026
5
SEC EDGARForm 4 filed Nov 5, 2024
6
SEC EDGARForm 4 filed Sep 4, 2024